Universal Health Services, Inc. (UHS)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for UHS is $205.56, 11.1% above the last close of $185.10 on Oct 16, 2026; targets range from $162.82 to $293.04. Rating consensus: Hold.
Snapshot
- P/E7.6x
- P/E vs sector-73.0%
- P/E vs own-7.6%
- Target upside+11.1%
- ConsensusHold
- Market cap$10.91B
- FCF yield+7.6%
- InsidersNone in 90d
- Earnings in11d
- News0.00
Why it moved
Universal Health Services, Inc. (UHS) fell 1.2% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.2).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $185.10 · -9.0% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI63
- Support-3.5%
- Resistance+1.5%
- Off 52w high-23.9%
- Off ATH-23.9%
- 52w range$185.10
- Bollingerupper half
- MACD0.85
- ATR+2.6%
- Volume0.9x
Analyst price targets
11 firms with a target in the last 12 months · last close $185.10 · as of Oct 16, 2026
Strong buy 1 · Buy 6 · Hold 13 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +8.3% year over year, free cash flow 4.7% of revenue, operating margin 11.1%.
| Q2 FY2026 | Jun 30, 2026 | $4.64B | 5.98 | $216M | 90.9% | 11.1% | 7.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.5B | 5.65 | $184M | 90.5% | 11.2% | 7.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.49B | 7.01 | $293M | 90.6% | 11.5% | 9.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.5B | 5.74 | $133M | 90.8% | 11.6% | 8.3% |
| Q2 FY2025 | Jun 30, 2025 | $4.28B | 5.43 | $283M | 90.2% | 11.7% | 8.2% |
| Q1 FY2025 | Mar 31, 2025 | $4.1B | 4.80 | $121M | 90.2% | 11.1% | 7.7% |
| Q4 FY2024 | Dec 31, 2024 | $4.11B | 4.96 | $412M | 90.1% | 11.5% | 8.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.96B | 3.80 | $85.05M | 90.2% | 9.7% | 6.5% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 2 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 3 |  | $72.57 | +0.1% | -0.1% | -7.0% | 62.6 | $11.38B | |
| 4 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B | |
| 5 | | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B | |
| 6 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 7 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B | |
| 8 |  | $86.38 | -0.7% | -4.9% | +6.0% | 25.2 | $9.63B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.